Results 231 to 240 of about 47,734 (349)

Results from the 32‐week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 2, Page 274-284, February 2026.
During the extension phase of the 32‐week DISCREET trial, apremilast treatment in patients with moderate to severe genital psoriasis led to clinically meaningful improvements in disease severity (modified genital PGA, overall sPGA, BSA), symptoms (genital itch, GPSS), and quality of life (DLQI, DLQI‐Q9), with safety outcomes consistent with prior ...
Joseph F. Merola   +11 more
wiley   +1 more source

From Barns to Bushes: Exploring the ECOFF‐Based Non‐Wild‐Type Status of Campylobacter spp. in Pets, Livestock, Synanthropic Birds and Wild Animals in Northwestern Italy

open access: yesZoonoses and Public Health, Volume 73, Issue 1, Page 30-44, February 2026.
ABSTRACT Introduction Antimicrobial resistance (AMR) poses a significant threat to both humans and animals. Zoonotic bacteria, such as Campylobacter, contribute to human infections and the spread of AMR, particularly through livestock, pets and wildlife. We investigated the prevalence, distribution and EUCAST ECOFF‐based wild‐type (WT) vs.
Aitor Garcia‐Vozmediano   +8 more
wiley   +1 more source

Visual field shape and foraging ecology in diurnal raptors

open access: yesJournal of Experimental Biology, 2018
Simon Potier   +6 more
semanticscholar   +1 more source

Unveiling the Myth: Harpy Eagle <i>Harpia harpyja</i> Attacks on a Human in the Amazon Forest. [PDF]

open access: yesEcol Evol
Epelboin L   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy